This includes sleep apnea, type 2 diabetes, coronary heart disease, respiratory system disorders, and pain syndromes, like osteoarthritis that is exacerbated nocturnally by TNFα, IL-1β, and other somnogenic immunological modulators [23,25,74,75,76,77,78]. This evidence concerns the gene IL1B and coronary artery disorder.